-+ 0.00%
-+ 0.00%
-+ 0.00%

BIOXCEL THERAPEUTICS - DEAL WITH TEVA INCLUDES $57.5 MLN CASH, UP TO $67.5 MLN DEVELOPMENT MILESTONES, $20 MLN COMMERCIAL MILESTONES - SEC FILING

Reuters·08/28/2026 10:09:59

Please log in to view news